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SUMMARY
Outbreaks of foot-and-mouth disease persist in dairy cattle herds in Saudi Arabia despite
revaccination at intervals of 4-6 months. Vaccine trials provide data on antibody responses
following vaccination. Using this information we developed a mathematical model of the decay
of protective antibodies with which we estimated the fraction of susceptible animals at a given
time after vaccination. The model describes the data well, suggesting over 95 % take with an
antibody half-life of 43 days. Farm records provided data on the time course of five outbreaks.
We applied a 'SLIR' epidemiological model to these data, fitting a single parameter
representing disease transmission rate. The analysis provides estimates of the basic
reproduction number, R, which may exceed 70 in some cases. We conclude that the critical
intervaccination interval which would provide herd immunity against FMDV is unrealistically
short, especially for heterologous challenge. We suggest that it may not be possible to prevent
foot-and-mouth disease outbreaks on these farms using currently available vaccines.
INTRODUCTION
Successful vaccination programmes prevent major
epidemics of an infectious disease by generating 'herd
immunity', which results when too few susceptibles
remain in the population to sustain disease trans-
mission [1, 2]. The establishment of herd immunity is
made more difficult by strain variation in the
infectious agent, varied host response to vaccination,
and vaccines which provide only partial protection for
a limited period of time [1, 3, 4]. These circumstances
apply to a number of diseases of domestic animals,
including foot-and-mouth disease.
Foot-and-mouth disease virus (FMDV) is an
important and widespread pathogen of domestic
livestock, responsible for lost productivity and restric-
tions on exports costing an estimated US$50 billion
annually worldwide [5]. There is considerable debate
regarding the optimal means of prevention and
control, particularly in Europe where the EU has
recently introduced a non-vaccination policy, pre-
ferring to rely on import controls and quarantine to
prevent the introduction of the virus. Countries
wishing to make animal exports to Europe are
therefore under considerable pressure to maintain
national herds free from FMDV. This has, however,
often proved extremely difficult, as illustrated by
recent epidemics in Zimbabwe and elsewhere [6].
In this paper we analyse data on vaccine trials and
on FMDV outbreaks on dairy cattle farms in Saudi
Arabia. The data are used to provide parameter
estimates for a mathematical model of the impact of
vaccination programmes at the population level [7, 8].
The model is based on standard epidemiological
theory [1] but includes a more detailed representation
of antibody responses to vaccination and the decay of
these responses through time. The model is used to
show why intensive vaccination programmes have
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failed to prevent outbreaks of FMDV on these Saudia
Arabian farms. The model suggests a general result
that vaccines giving short-lived protection are unable
to prevent epidemics of highly transmissible patho-
gens.
METHODS
Vaccination trial data
Data were available from two trials of commercial
vaccines in Saudia Arabian cattle using standard
methodologies [9, 10]. The trials involved 30 and 18
cattle over 6 months old and with a prior history of
vaccination. In both trials all cattle were simul-
taneously vaccinated. For the first trial FMDV-
specific total serum antibody titres were measured at
20, 50, 80 and 110 days post-vaccination. For the
second trial antibody titres were measured at 22 days
only. Maximum antibody titres are typically reached
7-10 days post-vaccination, although protective titres
may be reached after only 2-3 days post-vaccination.
Cattle are considered protected from foot-and-mouth
disease when antibody titres exceed 100 (as measured
by Liquid Phase Blocking ELISA), although this may
vary with the severity of challenge [11, 12].
Outbreak data
Records were available for 18 FMDV outbreaks
occurring on 12 dairy cattle farms in Saudi Arabia
between 1988 and 1993. The farms typically contained
1500-4000 cattle, although calf rearing stations may
be substantially larger. FMDV outbreaks affected
between 2% and 53 % of cattle on the farms despite
vaccination of every animal with commercial vaccines
at intervals of 4-6 months since 1986. The vaccines
contain both FMDV serotypes circulating in Saudi
Arabia. This regular vaccination of all cattle on the
farm is an example of a 'pulse' vaccination pro-
gramme [8]. Outbreaks have been reported as little as
18 days after vaccination. All cattle are revaccinated
within a few days of the first reported case in an
attempt to halt or slow the spread of infection.
Animals are quarantined as soon as clinical signs are
detected.
For five outbreaks on four farms data were
available on the time course of the outbreak, the
characteristics of the virus strain involved, and the
control measures adopted (Table 1); this information
allows a detailed analysis of these outbreaks. Three of
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High Aint A(t) Acat-log r Low
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Fig. 1. A schematic overview of the model of antibody decay. Log antibody titres immediately after vaccination (time 0)
are normally distributed around the mean A nt with variance 0.2. Those cattle with log antibody titres above the threshold
Acrit-log r (where r is degree of homology) are protected (immune) and those with log antibody titres below the threshold
are susceptible. Log antibody titre decays linearly through time at the rate y so mean log antibody titre at time t is given
by A(t) = Aint-Yt.
these outbreaks were type 0 virus (which were
antigenically similar to the vaccine strains) and two
were type A virus (and were also antigenically
different from the vaccine strain). We confined
attention to cattle over 6 months old, which had
already received at least a primary and booster
vaccination. This is because calves are normally kept
apart from the main herd and are maternally protected
(the mothers having been vaccinated) for 2-4 months.
As a result, outbreaks among calves are delayed,
typically by 20-25 days, and affect relatively few
animals, typically 2-3 %, and so have little or no
impact on the initial course of an outbreak. We also
tested for age-related patterns in the course of the
outbreak among cattle over 6 months old using
analysis of variance with cattle divided into five age
classes, based on the number of lactations.
Model of decay of antibody titre
We describe the distribution of log (base 10) antibody
titres by a normal probability density function,
N(A(t), 0.2), where A(t) is the mean log antibody titre
at time t after vaccination and the variance 0.2 is
independent of A and t. We assume an exponential
decay in antibody titre, and therefore, we can express
the mean log antibody titre at time t as A(t) =
Aint -yt where y is a measure of the rate of decay of
antibody titre and Aint is a measure ofvaccine potency.
We define a threshold log antibody titre, Aerit, below
which cattle are susceptible to challenge with a
homologous virus. It is possible that this threshold is
itself variable [13] (for example, due to variation in
challenge dose experienced by individual cattle) - if
so, the variance in Acrit, may be treated as additive to
02-but this is ignored here. For challenge with a
heterologous virus the effective threshold becomes
Acrit-log r where r is the ratio of serum antibody titre
against heterologous virus to the titre against hom-
ologous virus, referred to as the relative homology.
From these arguments we suggest an expression for
the proportion of cattle that have antibody titres
above the threshold at time t after vaccination. We
refer to this proportion as p(t) which is given by:
p(t) = 2erfc (ytAint+Acrit-log r) (1)
where the term erfc refers to the complement of the
error function [14]. A schematic representation of the
model is shown in Figure 1.
Note that, while Aint represents the nominal log
antibody titre at t = 0, in practice maximum anti-
bodies are not obtained until t = 10 days, and the
proportion initially protected by vaccination, referred
to as vaccine take, is therefore given by p(IO).
Model of FMDV outbreaks
The dynamics of the early stages of outbreaks are
described by the standard model for rates of change in
the numbers of cattle which are susceptible to
infection, S, latent (infected but not yet infectious), L,
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infectious, I, and removed, R. This is referred to as a
SLIR model and is written:
dS TH/-?SI, dL= ,SIw-L, (2a, b)
dI dR
dt dt (2c,d)
where herd size H= S+L+I+R; , is the trans-
mission rate, the per capita rate at which infectious
cattle infect susceptible cattle; w is the per capita rate
at which latent cattle become infectious, and so 1 /w is
the mean latent period; v is the per capita rate at which
infectious cattle are removed, and so 1/v is the mean
infectious period before cattle show clinical signs and
are removed from the population. The model assumes
that net transmission rates increase with herd size,
giving the term /3SI.
The parameter T= -dp/dt describes the rate of
recruitment of susceptibles at time t (appropriately
scaled) due to the loss of vaccine-induced protection
and is obtained from Equation (1), recalling that p is
the proportion of cattle protected by vaccination and
therefore declines through time. Another source of
new susceptible cattle is the recruitment of young
animals into the herd. For current purposes we
assumed that recruitment balances losses due to
mortality and that recruited animals have already
been subject to a similar vaccination schedule. In these
circumstances, recruitment will not change the distri-
bution of antibody titres in the population and so
does not affect the dynamics of the susceptible
class. Another factor which may affect the number of
susceptibles at the start of an outbreak is the prior
history ofFMDV infection, previously exposed cattle
may retain some immunity to subsequent infection. In
practice none of the five outbreaks occurred less than
4 years after a previous outbreak of the same virus
serotype in the same herd. Because this interval is
close to typical life-expectancy of cattle on these farms
(approximately 5 years) we assumed no previous
exposure to infection.
This model can be used to generate an estimate of
the basic reproduction number, R, for foot-and-
mouth disease in each of the farms at the time of each
outbreak. Ro is defined as the number of secondary
cases which would be obtained directly from a single
primary case in a fully susceptible population and is
given here by the expression:
Ro= H (3)
Clearly, major outbreaks cannot occur unless Ro is
greater than one [1]. If Ro is less than one then each
primary case, on average, fails to replace itself and the
outbreak will die out.
Calculation of the critical intervaccination interval
To provide herd immunity the maximum number of
susceptible cattle in the population must be kept
sufficiently low such that the basic reproduction
number in the vaccinated population never exceeds
one. As discussed above, the number of susceptibles
increases as vaccine-induced protection decays. The
minimum interval between vaccinations, Tent, must
satisfy the condition:
P(Tcrit) >,- 1-R'1Ro (4)
where p(t) is given by Equation (1) and R0 is given by
Equation (3).
Equation (4) assumes that antibody titres im-
mediately after vaccination are independent of both
the number of previous vaccinations and the time
interval since the previous vaccination, as is consistent
with available information [9] (recalling that all cattle
have had at least a primary and a booster vaccination
before entering the main herd).
Parameter estimation and model fitting
We estimated the rate decay of antibody titre, the
parameter y, as the slope of a least squares linear
regression of log antibody titre, A(t) against time, t.
We used analysis of covariance to test for different
slopes for individual cattle. The intercept of the
regression provides an estimate of Ai.t; this estimate
was scaled as an average including the results from the
second vaccine trial, which did not provide an
independent estimate of y. We estimated the variance
in log antibody titres, o-2, directly from data taken at
various times t from three different trials. Hom-
ogeneity of variances was tested using Bartlett's test
and the goodness of fit of the normal distribution to
the data was confirmed using the Kolgomorov-
Smirnov test [15].
Other parameter estimates were taken from existing
literature [16]. The latent period may vary from 2-14
days in individual cattle, but with a mean of 5 days,
giving wo = 02 per day. The duration of infectiousness
combines the period where cattle are infectious but
show no clinical signs (1-2 days) and any delay before
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cattle showing clinical signs are removed (0-1 days),
with a mean approximately 2 5 days, giving v = 0 4
per day.
We obtained estimates of the transmission rate, /?
for each outbreak by fitting the SLIR model to
observed values of the number of cattle removed, R,
through time. We fitted the model with a derivative-
free nonlinear regression package, the BMDP AR
routine, which uses a 5th order Runge-Kutta
approximation to provide a numerical solution to the
differential equations (2a)-(2d). We defined initial
conditions (corresponding to time t = 0, the time of
the first reported case) as follows: S(0) was obtained
from Equation (1) given the known time interval since
vaccination (Table 1); I(0) and L(0) were calculated
numerically, given the observed initial values of R.
For each outbreak we fitted the model for the period
up to 7 days after the herd was revaccinated to control
the outbreak (Table 1); any impact of revaccination
on transmission is expected to become apparent after
7-10 days.
From each outbreak we then calculated an estimate
of the basic reproduction number, Rog using Equation
(3). Note that the only parameters considered to differ
between outbreaks are the initial number of susce-
ptibles, S(0), (related to herd size and the interval
since vaccination) and the transmission rate, ,.
Using Equation (4) we explored the relationship
between the critical intervaccination interval, Terit,
and Ro for different virus relative homology, r. We
also explored the relationship between T1rit and the
half-life of vaccine-induced protection (which corres-
ponds to the time t where p(t) = 0.5 and is obtained
by taking different values for the rate of decay of
antibody titre, y) for different values of Aint, which
represent vaccines giving different initial levels of
protection.
RESULTS
Decay of antibody titre
The log antibody titres, A(t), obtained from 30 cattle
at four different times after vaccination are shown in
Figure 2. Analysis ofcovariance showed no significant
difference in slopes for individual cattle (F = 1.7;
D.F. = 29,60; P> 0-05). The best fit regression line
through the means has negative slope y = 0-00743
(± 0 000 77) with a coefficient of determination of 0-98
(P < 0 02). This value of y corresponds to antibody
half-life of 43 days. The average estimate of Ai t from
au4
4-
12060
Time, t (days)
Fig. 2. The decay of antibody titre. Data from a trial of
commercial FMDV vaccine in 30 cattle in Saudi Arabia.
Individual log antibody titres were measured at 20, 50, 80
and 110 days (symbols). The best fit linear regression for the
mean log antibody titre, A(t) against time t is shown (solid
line). This has the form A(t) = 2 73-0-00743t. The threshold
log antibody titre giving protection against homologous
virus, Acrit) is compared (horizontal line). Cattle with log
antibody titres above this threshold are protected and those
below this threshold are susceptible.
.
.................
20.8-
0
0
0 50 100 150 200
Time, t (days)
Fig. 3. The loss of vaccine-induced protection. Data as for
Figure 2. The fraction of animals with log antibody titres
above the protective threshold is shown at times 20, 50,
80 and 110 days. The expected fraction from Equation (1)
with parameter values Ain, = 2 73, y = 0 00743, o- = 0-352,
Acrit = 2-0 and r = 10 are shown (solid line). The expected
fractions for Aint corresponding to 70% and 999% take
(fraction protected at 10 days) with other parameters
identical are compared (broken lines).
the two trials is 2 73. The estimates of the variance of
log antibody titres, 0-2, from 11 different times during
three different trials were not significantly different
(X2 = 15-23; D.F. = 10; P > 0-10) and the weighted
mean variance gave common C- = 0-352. The distri-
butions of A(t) values shown in Figure 2 are well
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Fig. 4. FMDV outbreaks on cattle farms in Saudi Arabia:
type 0 virus. Data are from three outbreaks on two different
farms (see Table 1). Numbers of infected animals removed,
R, are shown (symbols). The expected values from Equa-
tions (2a-d) with parameter values a) = 0-2 and v = 0-4 and
with fitted are compared (solid line). The initial number of
susceptibles, S(0), is estimated using Equation (1) (see Table
1). The model is fitted up for up to 7 days following
revaccination (indicated by arrows).
described by a normal distribution with mean A(t)
and variance o.2, except for a slight discrepancy at
t = 1 10 (Kolgomorov-Smirnov Dmax = 0-164; n = 30;
P = 0-045). These parameter values correspond to
vaccine take, the fraction protected at t = 10 days, of
96-9%.
Using the same data as shown in Figure 2 the
fraction of cattle with antibody titres above the
>0
4)
z
/UU
600
500
400
300
200
100
0 0 5 10 15 20
150
100
50-
U
A'/
0 5 10
Time, t (days)
15 20
Fig. 5. FMDV outbreaks on cattle farms in Saudi Arabia:
type A virus. Data are from two outbreaks on different
farms (see Table 1). Other details are as for Figure 4 except
that S(0) is now estimated taking into account low virus
homology.
protective threshold against time are shown in Figure
3. The expected fraction protected obtained from
Equation (1) with the values of Aint, o- and y given
above are compared. Chi-squared tests show that the
expected and observed values are not significantly
different for any value of t (x2 < 1, D.F. = 1, P >
0-10). The half-life of vaccine-induced protection
(corresponding to t when p(t) = 0-5) is 98 days. Also
illustrated in Figure 3 are the expected fractions
protected against time for vaccines with take 70% and
99-9 %, calculated using the appropriate values of Aint
but assuming the same value of y. This represents the
full range of observed vaccine takes normally encoun-
tered [10].
FMDV outbreaks
The cumulative numbers of cattle infected and
removed, R, over the first 20 days of three outbreaks
of Type 0 FMDV and of two outbreaks of Type A
U M
- -m -0 . . .
a
4I
10 15 2(
'7nAA
v
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Fig. 6. The relationship between critical intervaccination
interval, Trit, and the basic reproduction number R0 (log
scale). Graph is plotted using Equation (4) with parameter
values as for Figure 3. Different degrees of virus homology,
r, are compared (values shown).
FMDV are shown in Figures 4 and 5 respectively. The
times of revaccination are also indicated.
Analysis of variance showed no significant effects of
age on the day of the outbreak (normalized by square-
root transformation) of the first reported case in the
age class (F= 1-97; D.F. = 4,16; P> 010) or the
(arcsine square-root transformed) fraction of cattle
affected in the age class (F= 1-47; D.F. = 4,12; P >
0 20) for the five outbreaks of interest. This implies
that cattle over 6 months old can be considered as a
single population in each case.
The estimated initial number of susceptibles, S(0),
for each outbreak, obtained using Equation (1) are
given in Table 1. Fitting the model represented by
Equations (2 a)--(2 d) provides estimates of/ for each
outbreak. With this one fitted parameter the model
describes the data well (Figs 4 and 5) and, in most
cases, also provides an indication of the impact of
revaccination as an obvious change in trajectory 7-10
days later. The estimates of /, vary considerably
between outbreaks, by a factor of 50 or more (Table
1). This variability translates into high variability
in the estimates of the basic reproduction number,
RO, with values ranging from 2 to more than 70
(Table 1).
*0
.k
0*00 1-69 3-38
Antibody half life (months)
5*11
Fig. 7. The relationship between critical intervaccination
interval, T7rit, and the duration of protection. Graph is
plotted using Equation (4) with duration of protection
expressed as the half-life (corresponding to 50% animals
still protected) or, alternatively, the half-life of protective
antibodies. Different initial antibody titres, Aint (corre-
sponding to different vaccine take) are compared (values
shown).
Critical intervaccination interval
The relationship between the critical intervaccination
interval, T7rit, and Ro is shown in Figure 6. Using a
vaccine with the characteristics described above, for
homologous challenge (r = 1 0) 7Crit decreases rapidly
as R0 increases. 7Crit is substantially lower for
heterologous challenge (r < 10).
The relationship between T7rit and the half-life of
vaccine-induced protection is shown in Figure 7.
From a given vaccine take (represented by Aint) T7rit
increases almost linearly with half-life. T7rit is lower
for vaccines with lower take (lower Aint).
DISCUSSION
The model represented by Equation (1) appears to be
a good description of the decay of antibody titres (Fig.
2) and of the decay in the fraction of cattle protected
following vaccination (Fig. 3). This description is
based on three well defined and measurable quantities:
the rate of decay of antibody; the shape of the
population distribution of antibody titres; and the
peak vaccine-induced antibody levels. In this study
If
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the antibody decay function was consistent with an
exponential form and the antibody titre distribution
with a log-normal form. For a vaccine with 96 9%
take (fraction of cattle protected 10 days after
vaccination) 50% cattle are expected to be still
protected 98 days after vaccination, a measure of the
half-life of vaccine-induced protection. This half-life
may be higher (or lower) for vaccines giving higher (or
lower) take (Fig. 3). It is not known whether different
vaccine batches produce different rates of decay of
antibody titre, which would further affect the half-life
of vaccine-induced protection.
The fraction of susceptibles in a herd at any time
after vaccination represents those individuals where
the vaccine failed to take, those individuals where
vaccine-induced protection has been lost, and any
susceptibles newly recruited into the herd. Suscep-
tibility also reflects the homology of the challenge
virus. For the outbreaks analysed here (Table 1) the
susceptible fraction was estimated to range from 23 %
(challenge by antigenically similar virus 65 days after
vaccination) to close to 100% (challenge with a virus
antigenically very different from the vaccine strain 75
days after vaccination). For all five outbreaks the
estimated number of susceptibles was, as required,
greater than the lower limit represented by the number
of animals actually infected during the outbreak
(Table 1). The uncertainty associated with the estimate
of the susceptible fraction is difficult to determine
directly but is of the order of a factor 2 (see Fig. 3 and
Table 1).
In contrast, the estimates ofthe disease transmission
rate obtained from fitting Equations (2a)-(2d) to the
outbreak data vary by a factor of 50 or more (Table
1). This is much greater than might be explained by
errors in the estimation of the number of susceptibles.
Other possible explanations include differences be-
tween virus serotypes (the lowest value is associated
with Type A, the highest with Type 0), or differences
in environmental conditions and husbandry practices
between farms which result in more or less favourable
conditions for virus transmission (the two Type 0
outbreaks at the same farm give similar transmission
rates). The variability in transmission rates translates
into variability in the estimate of the basic repro-
duction number, Rog (Table 1) which is additionally
influenced by variability in herd size (see Equation 3).
The basic reproduction number may exceed 70, which
indicates very high virus transmissibility.
The SLIR model represented by Equations
(2 a)-(2 d) provides a good description of the early
stages of the five outbreaks (Figs. 4 and 5). The impact
of revaccination can be seen by obvious changes in the
trajectory of the outbreak 7-10 days later although
transmission did not completely cease at this time. In
the absence of revaccination or other control measures
the model predicts that almost all susceptible cattle
would become infected (unless Ro is below 2) [1].
If major outbreaks are to be prevented in these
herds then the basic reproduction number in the
vaccinated herd must be reduced below one, which
constitutes herd immunity. Although the available
vaccines may give good take the duration of pro-
tection afforded is low compared with cattle life
expectancy; this implies that revaccination must be
given at frequent intervals if herd immunity is to be
achieved. Current vaccination programmes (revac-
cinating every 4-6 months) should provide herd
immunity against antigenically similar virus only if Ro
is below 2 (Fig. 6). The situation would be greatly
improved if vaccines with greater duration of pro-
tection were available (Fig. 7). The problem is worse
for antigenically different virus; for example, it is not
possible, however frequently cattle are revaccinated,
to prevent outbreaks of a virus with relative homology
0 6 if Ro exceeds 10 (Fig. 6).
These results suggest that currently available vacc-
ines are unlikely to be able to prevent FMDV
outbreaks on these cattle farms, however frequently
the animals are vaccinated. This is because of the high
transmissibility of FMDV on the farms, the short
duration of vaccine-induced protection and the pres-
ence of antigenically different viruses. Alternative
preventative measures might include the change of
husbandry practices to reduce virus transmission
rates; for example, by maintaining cattle at lower
densities or the more rapid removal of infectious
animals. However, the results do suggest that vac-
cination can be effective in reducing transmission
rates once an epidemic has begun, as has been
discussed elsewhere [17].
The results also have implications for vaccines
developed for other animal diseases such as kennel
cough, feline leukaemia, feline influenza, equine
influenza, equine rhinopneumonitis, orf and
parainfluenza-3. Although take, at least against
homologous challenge, may be high, these vaccines
provide protection for limited periods and even very
intense vaccination programmes are unlikely to result
in herd immunity and so prevent outbreaks of disease.
Trials of new candidate vaccines should be designed
to assess the duration of protection, which will be a
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major factor determining their potential for disease
control at the population level.
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